We would like to extend a warm welcome to three new Investment Associates joining the Kairos team: Adnan Husain, Aaron Keefe, and Andrew Lewis. We are excited to grow our investment research team to handle the increased demands of our growing deal pipeline. Adnan, Aaron, and Andrew will be based in our Pasadena office and report to Alex Andrianopoulos, Chief Research and Development Officer at Kairos Ventures.

Adnan Husain, MD, JD. Adnan joins Kairos Ventures from Austin, Texas, where he was a pharmaceutical patent litigation associate (ANDA/Hatch-Waxman) at Farney Daniels PC. Dr. Husain holds a Doctor of Medicine from the University of Illinois at Urbana-Champaign, a Jurisprudence from University of Illinois College of Law, and a Bachelor of Science and Master of Science in biomedical engineering and Bachelor of Arts in Economics from Washington University in St. Louis.

Aaron Keefe. Aaron was a Senior Analyst at Scientia Advisors in Cambridge, Massachusetts and a Manager of Marketing Strategy and Planning at Healthnet in Woodland Hills, California prior to joining Kairos Ventures. Mr. Keefe has a Bachelor of Science in Economics from Duke University and a Master of Science in Biomedical Engineering from UCLA.  Aaron has also completed courses and research towards a Master of Science in Mechanical Engineering, Immunology and Tissue Engineering at Carnegie Mellon University.

Andrew Lewis. Andrew was a graduate student consultant focused on corporate strategy at Edwards Lifesciences and an IP & Technology Transfer Analyst and Industry Ambassador at Keck Graduate Institute in Claremont, California before joining Kairos Ventures. Mr. Lewis holds a Bachelor of Science in Molecular Biology, Psychology and Philosophy from the University of Illinois at Urbana-Champaign, a Master of Bioscience, Business Administration and Management from Keck Graduate Institute and a Certificate of Bioscience Industry and Law Practice from Southwestern Law School.

Welcome Adnan, Aaron and Andrew to the Kairos Ventures team!